Compare Cardinal Health Inc (CAH) vs VanEck Gold Miners ETF (GDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs VanEck Gold Miners ETF — how do they compare? Cardinal Health Inc trades at $228.59 (market cap $53.89B), while VanEck Gold Miners ETF trades at $74.82. The key difference: Cardinal Health Inc pays a 0.89% dividend while VanEck Gold Miners ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, VanEck Gold Miners ETF nearer its low. Which is the better fit depends on your goals.
| CAH | GDX | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | — |
52-Week High | $239.71 | $115.84 |
52-Week Low | $146.04 | $51.15 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
GDX, the VanEck Gold Miners ETF, trades at $73.37, down 2.86% in the last 24 hours amid a bearish technical signal from moving averages. The fund's valuation metrics are not available, but recent news highlights competition from lower-fee gold ETFs and a recent addition of Aya Gold & Silver to its holdings. Technical indicators show neutral oscillators with key support at $71 and resistance at $74.
The outlook for GDX is cautious due to underperformance versus physical gold and higher volatility. Investment opportunities lie in potential gold price rebounds and record-high free cash flow yields, but risks include fee disadvantages and sector-specific volatility. Analyst sentiment is mixed, with some seeing a buying opportunity amid low valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About VanEck Gold Miners ETF
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →
